Innovation and Patient Access to Personalized Medicine
Conference, Dublin, 20th -21st of March 2013
The European Development Platform represented Romania to the conference Innovation and Patient Access to Personalized Medicine organized by EAPM under the Irish Presidency of the EU, in Dublin on March 20-21.
The emerging field of personalized medicine is offering innovative ways of tackling Europe’s health issues. But Europe’s healthcare system is not yet fully adapted to take advantage of the possibilities. How can patients get access to the benefits that are on the brink of becoming available through personalized medicine?
The meeting brought together researchers, patients, physicians, regulators and politicians, to explore the current barriers and how they can be dismantled. Expert panels examined the potential ways through the obstacles that Europe currently poses – in relation to clinical trials, the links between diagnosis and treatment, reimbursement, training of healthcare professionals, and sharing of data.
A clear outline was presented of what personalized medicine has achieved to date, and what it can achieve in the future – for patients, for healthcare systems, and for Europe’s international competitiveness.
Speakers: John Bowis, OBE, Co-chair EAPM, John Perry, Minister of State, Ireland, Patricia Reilly, Member Cabinet, Commissioner Máire Geoghegan-Quinn, European Commission, Michel Goldman, Executive Director, Innovative Medicines Initiative Tom Lillie, International Therapeutic Area Head Oncology, Amgen Limited, Roger Wilson, Sarcoma UK.